Skip to main content
. 2019 Jul 25;9(8):157. doi: 10.3390/metabo9080157

Table 1.

Cohort characteristics.

Variable Non-Smokers Smoking Controls COPD p-Value
n 12 56 47
Sex, % men 33 45 62 0.104
Race,% White 50 73 87 7.48 × 10−3 *
Race, % Black 25 21 6 7.48 × 10−3 *
Race, % Asian 17 2 4 7.48 × 10−3 *
Race, % other 8 4 2 7.48 × 10−3 *
Age, yr 56 (50–60) 58 (50–66) 64 (58–68) 7.95 × 10−4 *
Current smokers, % 0 36 36 2.68 × 10−2 *
Pack–years 0 (0–0) 34 (26–44) 42 (34–60) 3.95 × 10−11 *
Body mass index 26.21 (5.46) 28.78 (4.47) 28.9 (5.27) 0.198
Chronic bronchitis, % 0 (0) 7 (26) 15 (36) 0.294
Exacerbations/yr 0.08 (0.29) 0.12 (0.43) 0.39(0.68) 0.117
Emphysema, % 0.15 (0.06–1.22) 0.16 (0.05–0.4) 1.05 (0.32–2.5) 2.90 × 10−3 *
FEV1 % 99.29 (7.31) 100.23 (13.1) 78.97 (19.92) 3.87 × 10−8 *
FEV1/FVC 81 (77–87) 78 (75–81) 61 (55–67) 5.31 × 10−24 *

Data are presented as median (interquartile range) or mean ± SD. * p-value < 0.05. Emphysema, %: % Emphysema voxels (<−950 Hounsfield units) in lung CT (Computed Tomography) image. Exacerbations/yr: # of exacerbations in last year. Chronic bronchitis: Daily productive cough for at least 3 months in the previous 2 consecutive years. % FEV1: Postbronchodilator % predicted forced expiratory volume in one second. FEV1/FVC: Ratio of forced expiratory volume in one second to forced vital capacity. COPD: chronic obstructive pulmonary disease.